Science

New Study Reveals Potential of Symbiotic Bacteria as Molluscicides Against Deadly Parasite Carrier

2024-12-22

Author: Arjun

Introduction

A recent study highlights a promising breakthrough in the fight against schistosomiasis, a disease affecting over 250 million people worldwide, primarily spread by the aquatic snail *Biomphalaria glabrata*. This snail acts as an intermediate host for *Schistosoma mansoni*, the trematode responsible for the most prevalent form of schistosomiasis in humans.

Background

Schistosomiasis isn't just a health issue; it’s a global crisis exacerbated by disruptions from the COVID-19 pandemic, which has hindered control measures. With no effective vaccine currently available, and existing treatments such as mass drug administration (MDA) using praziquantel falling short of complete efficacy, researchers are now looking at innovative solutions to disrupt the lifecycle of these snails and thereby control the disease's spread.

Challenges with Traditional Molluscicides

Traditional molluscicides, including niclosamide, are used to manage snail populations but come with significant drawbacks, such as toxicity to other aquatic species, resistance in snail populations, and high costs. In this climate, the exploration of alternative biological control agents, particularly those derived from the natural interactions between nematodes and their symbiotic bacteria, has gained traction.

Research Focus on Symbiotic Bacteria

Researchers studied the symbiotic bacteria *Xenorhabdus* and *Photorhabdus*, notorious for their potent insecticidal properties when associated with entomopathogenic nematodes (EPNs) like *Steinernema* and *Heterorhabditis*. These bacteria release harmful secondary metabolites upon infecting their hosts, killing insects within a mere 24 to 48 hours.

Findings of the Study

The focus on these symbiotic bacteria was driven by their potential as biological molluscicides. Previous research indicated that they could be pathogenic to gastropod snails, but no one had yet explored their molluscicidal activity against *B. glabrata* specifically.

In the study, researchers successfully isolated five EPNs and tested the molluscicidal effect of extracts from their associated bacteria. Remarkably, both *Xenorhabdus stockiae* and *Photorhabdus laumondii subsp. laumondii* exhibited an impressive 100% mortality rate in snails within 72 hours when applied at a concentration of 100 µg/mL, a level well below the WHO recommended threshold for plant-based molluscicides. This is a significant finding, suggesting that these extracts can be a game-changer in controlling snail populations effectively and sustainably.

Mode of Action and Histopathological Effects

The study also delved into the mode of action of these extracts and revealed substantial histopathological changes in vital snail tissues. Specifically, the extracts caused damage to the foot region, digestive glands, and hermaphrodite glands of the snails, indicating their lethal effects at a cellular level. Following exposure, the snails displayed necrotic changes, with observable impacts on their reproductive tissues and digestive systems, mirroring effects seen with traditional molluscicides like niclosamide.

Advanced Techniques in Research

Furthermore, the researchers employed advanced techniques like liquid chromatography-tandem mass spectrometry (LC–MS/MS) to identify bioactive compounds produced by the bacteria, leading to discoveries of various secondary metabolites that contributed to their molluscicidal properties.

Conclusion

In conclusion, this groundbreaking research opens new avenues for controlling schistosomiasis by targeting its transmission vectors. The use of *Xenorhabdus* and *Photorhabdus* as natural molluscicides presents a promising strategy for environmentally friendly management of snail populations, potentially revolutionizing current control measures in public health. As researchers continue to explore the full extent of these bacteria's capabilities, this could lead to a significant decline in schistosomiasis cases worldwide.

Stay tuned for more updates as the scientific community delves deeper into these promising biological control agents!